期刊文献+

羧基荧光素乙酰乙酸对大鼠骨髓间质干细胞体外染色的研究 被引量:3

Mesenchymal Stem Cells of Rats Stained by Carboxyfluorescein Diacetate Succinimidy Esterin vitro
暂未订购
导出
摘要 目的探讨活体染料羧基荧光素乙酰乙酸(CFSE)标记大鼠骨髓间质干细胞(MSCs)的可行性和最适条件。方法清洁型SD大鼠20只,用密度梯度离心结合贴壁法分离、纯化、培养大鼠MSCs,取长满25cm×25cm培养瓶瓶底的第3代大鼠MSCs,用2.5,5,10,20,40μmol/L的CFSE分别作用1,5,10,15,20min后染色,通过观察染色后细胞荧光强度和细胞贴壁率筛选出CFSE标记大鼠MSCs的最佳标记时间和标记浓度。采用MTT法检测最佳条件CFSE标记的大鼠MSCs的增殖能力。结果浓度10μmol/L的CFSE在37℃下孵育10min为MSCs染色、观察和研究的最佳条件。此条件下,CFSE标记的MSCs的增殖能力不受影响。结论活体染料CFSE是一种标记率高、细胞毒性小、操作简便的标记大鼠MSCs的新方法,浓度10μmol/L的CFSE在37℃下孵育10min为CFSE标记大鼠MSCs的最佳条件。 Objective To investigate the feasibility of labeling mesenchymal stem cells(MSCs) of rats with 5,6,2-carboxyfluorescein diacetate suecinimidy ester(CFSE)and the optimal condition. Methods MSCs obtained from 20 SD rats' bone marrow were isolated, purified and cultured in vitro with Percoll density gradient centrifugation combined with adherent method. MSCs of the third generation MSCs filling in the floor of 25cm^2 cultured bottles were incubated with 2.5,5,10,20, and 40μmol/L of CFSE for 1, 5,10,15, and 20 min respectively. The optimal concentration and labeling time of CFSE were indentified by detecting the fluorescence intensity and adhesive rate of labeled MSCs. The proliferative activity of MSCs labeled by CFSE under the fittest condition was tested by MTT method. Results Incubation with 10μmol/L of CFSE under 37 ℃ for 10 minutes was the optimal condition for MSCs labeling. The labeled MSCs maintained the same proliferative ability as the non- labeled MSCs under the optimal condition. Conclusion With the advantages of high rate of dyeing, low cell toxicity, safety and convenience,CFSE can be used as a new method to label the rat's MSC. Incubation with 10μmol/L of CFSE under 37℃ for 10 minutes is the optimal condition for MSCs labeling.
出处 《福建医科大学学报》 2008年第6期482-486,共5页 Journal of Fujian Medical University
基金 教育部博士学科点科研基金(2006E+10)
关键词 荧光素 乙酰乙酸盐类 骨髓细胞 间质干细胞 染色与标记 大鼠 fluorescein acetoacetates bone marrow cells mesenchymal stem cells staining and labeling rats, sprague-dawley
  • 相关文献

参考文献11

  • 1Jorgensen C, Djouad F, Apparailly,et al. Engineering mesenchymal stem cells for immuntherapy [J]. Gene Therapy, 2003,10(3) :928-931.
  • 2Miura M, Miura Y,Sonoyama W,et al. Bone marrow-derived mesenehymal stem cells for regenerative medicine in craniofacial region[J]. Oral Dis ,2006,12(6) : 514-518.
  • 3Baan C C, Mast B J,Klepper M,et al. Differential effect of calcineurin inhibitors, anti-CD25 antibody and rapamyein on the indution of FOXP3 in human T cells[J]. Transplantation, 2005,80(1) : 110-117.
  • 4洪介民,黎庆梅,吕海峰,林之瑜.CFSE标记细胞的影响因素探讨[J].广东药学院学报,2006,22(5):541-543. 被引量:3
  • 5许剑,徐格林,刘新峰.骨髓基质干细胞的标记示踪技术及其应用[J].中国临床神经科学,2006,14(2):197-201. 被引量:9
  • 6Sakai T, Li R K, Weisel R D, et al. Autologous heart cell transplantation,improve cardiac function after myocardial injury[J]. Ann Thorac Surg, 1999,68(7): 2074-2081.
  • 7Dunnwald M,Chinnathambl S, Alexandrunas D,etal. Mouse epidermal stem cells proceed through the cell cycle[J]. J Cell Physiol, 2003,195(1) :194-201.
  • 8Ishiwata N, Suzuki S, Ando, et al. Characteristics and biodistribution of cationic liposomes and their DNA complexes[J]. J Control Rel, 2000,69(1): 139-148.
  • 9Arhsall E. Geae therapy death prompts review of adenovirus vector[J]. Science, 2000,286(3) :2244-2245.
  • 10付霞霏,何援利.大鼠间充质干细胞的体外分离培养及CFSE标记[J].解放军医学杂志,2007,32(5):464-466. 被引量:8

二级参考文献37

  • 1王玲,王宏,刘越坚,吴泰华,王丽颖,于永利.利用CFSE标记检测CD8^+淋巴细胞增殖[J].大连医科大学学报,2004,26(4):262-264. 被引量:4
  • 2Jorgensen C,Djouad F,Apparailly F,et al.Engineering mesenchymal stem cells for immunotherapy[J].Gene Therapy,2003,10:928-931
  • 3Matsushita T,Oyamada M,Kurata H,et al.Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction[J].Circulation,1999,100 (Suppl Ⅱ):262-281
  • 4Gratzner HO.Monoclonal antibody to 5-bromo-and 5-iodo-deoxyuridine:A new reagent for detection of DNA replication[J].Science,1982,218:474
  • 5Lee KH,Yoon do H,Park YG,et al.Effects of glial transplantation on functional recovery following acute spinal cord injury[J].J Neurotrauma,2005,22:575-589
  • 6Qu TY,Dong X J,Sugaya K,et al.Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells[J].Restor Neurol Neurosci,2004,22:459-568
  • 7Sakai T,Li RK,Weisel RD,et al.Autologous heart cell transplantation improves cardiac function after myocardial injury[J].Ann Thorac Surg,1999,68:2074-2081
  • 8Fischell TA,Carter A J,Laird JR.The beta-particle-emitting radioisotope stent (isostent):animal studies and planned clinical trials[J].Am J Cardiol,1996,78(suppl 3A):45-50
  • 9Haas J,Bauer P,Rolfs A,et al.Immunocytochemical characterization of in vitro PKH26-labelled and intracerebrally transplanted neonatal cells[J].Acta Histochem,2000,102:273-280
  • 10Chandra P,Mildner B,Dann O,et al.Influence of 4'-6' diamidino-2-phenylindole on the secondary structure and template activities of DNA and polydeoxynucleotides[J].Mol Cell Biochem,1977,18(2-3):81-86

共引文献18

同被引文献55

  • 1Rakesh P Patel,John D Lang,Alvin B Smith,Jack H Crawford.Redox therapeutics in hepatic ischemia reperfusion injury[J].World Journal of Hepatology,2014,6(1):1-8. 被引量:9
  • 2Maryam Ayatollahi,Maryam Kabir Salmani,Bita Geramizadeh,Seyed Ziaadin Tabei,Masoud Soleimani,Mohammad Hosein Sanati.Conditions to improve expansion of human mesenchymal stem cells based on rat samples[J].World Journal of Stem Cells,2012,4(1):1-8. 被引量:5
  • 3胡荣昕,缪伟峰.肝纤维化动物模型的研究概况[J].实用肝脏病杂志,2007,10(2):133-135. 被引量:11
  • 4陈少强,林建华.骨髓间充质干细胞移植治疗脊髓损伤的研究现状[J].中国修复重建外科杂志,2007,21(5):507-511. 被引量:20
  • 5Meirelles L D, Fontes A M, Covas D T, et al. Mechanisms involved in the therapeutic properties of mesenchymal stem ceils. Cytokine Growth Factor Rev, 2009, 20:419 -427.
  • 6Bernardo M E, Locatelli F, Fibbe W E. Mesenchymal stromal cell. Ann NY Acad Sci,2009,1176:101 -117.
  • 7Manuelpillai U, Moodley Y, Bodongan C V, et al. Amniotic membrane and amniotie cells: Potential therapeutic tools to combat tissue inflammation and fibrosis. Placenta, 2011, 32 : 320-325.
  • 8Takami T, Terai S, Sakaida I. Advanced therapies using autologous bone marrow cells for chronic liver disease. Discov Med, 2012, 14(74) :7-12.
  • 9Russo F P, Parola M. Stem cells in liver failure. Best Praet Res Clin Gastroenterol, 2012, 26(1 ):35-45.
  • 10Takami T, Terai S, Sakaida I. Stem cell therapy in chronic liver disease. Curt Opin Gastroenterol. 2012 ;28 ( 3 ) : 203-208.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部